Evidence map›Paper›PMID 39897400›Full record

ReviewToxicology reports2025

Recent developments on ursolic acid and its potential biological applications.

R Arulnangai, H Asia Thabassoom, H Vajiha Banu, K Thirugnanasambandham, R Ganesamoorthy

Abstract readReview
In one paragraph

Review in Toxicology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Unlocking the Potential ofFoods (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Naturally Derived SENP1 Inhibitors with Anticancer Activity.International journal of molecular sciences · 2025
    Review
  11. International journal of molecular sciences · 2025
    Review
  12. Article
  13. Review
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

R ArulnangaiPG & Research Department of Chemistry, Jamal Mohamed College, Trichy, Tamil Nadu, India.
H Asia ThabassoomPG & Research Department of Chemistry, Jamal Mohamed College, Trichy, Tamil Nadu, India.
H Vajiha BanuPG and Research Department of Microbiology, Jamal Mohamed College, Trichy, Tamil Nadu, India.
K ThirugnanasambandhamNammazhvar Organic Farming Research centre, Tamil Nadu Agricultural University, Lawley Road, Coimbatore, Tamil Nadu 641 003, India.
R GanesamoorthyDepartment of Chemistry, Vinayaka Mission's Kirupananda Variyar Arts and Science College, Salem, Tamil Nadu, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A naturally occurring pentacyclic triterpenoid, ursolic acid (UA) has attracted a lot of interest due to its various pharmacological characteristics and its medical uses. The goal of this thorough review is to present a thorough examination of the therapeutic benefits of UA, including its anti-inflammatory, antioxidant, anticancer, antibacterial, and metabolic-regulating properties. We go over its origins, pharmacological characteristics, and advantages in the treatment of several illnesses, including cancer, neurological disorders, metabolic disorders, and cardiovascular diseases. We further emphasize its potential to improve exercise capacity and its growing function as an exercise mimic. UA's therapeutic potential is thoroughly explained in this review, which highlights the compound's potential as a natural remedy for several illnesses.

Indexed as

AntimicrobialHyperlipidaemiaMetabolic HealthNeuroprotectiveUrsolic acid

Identifiers

PMID39897400
PMCPMC11786699

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.